Dopamine agonists for preventing ovarian hyperstimulation syndrome-Reference-Cited by-同舟云学术

Dopamine agonists for preventing ovarian hyperstimulation syndrome

Published:2016-11-30 Issue: Volume: Page:
ISSN:1465-1858
Container-title:Cochrane Database of Systematic Reviews
language:en
Short-container-title:

Author:

Tang Huilin¹,Mourad Selma²,Zhai Suo-Di³,Hart Roger J⁴

Affiliation:

1. Peking University Third Hospital; Department of Pharmacy; 49 North Garden Rd Haidian District Beijing China 100191

2. Radboud University Medical Centre; Nijmegen Netherlands

3. Peking University Third Hospital; Department of Pharmacy, Therapeutic Drug Monitoring and Clinical Toxicology Center of Peking University; 49 North Garden Rd Haidian District Beijing China 100191

4. The University of Western Australia, King Edward Memorial Hospital and Fertility Specialists of Western Australia; School of Women's and Infants' Health; 374 Bagot Road Subiaco, Perth Western Australia Australia 6008

Publisher

Wiley

Subject

Pharmacology (medical)

Reference94 articles.

1. Role of quinagolide (Norprolac) in preventing ovarian hyperstimulation syndrome (OHSS) in high risk intracytoplasmic sperm injection (ICSI) patients;Alhalabi;Fertility and Sterility,2010

2. Quinagolide reduces OHSS in high risk ICSI patients;Alhalabi;Human Reproduction,2011

3. The dopamine agonist cabergoline prevents moderate-severe early ovarian hyperstimulation syndrome (OHSS) in high-risk ART patients;Alvarez;Human Reproduction,2006

4. Dopamine agonist cabergoline reduces hemoconcentration and ascites in hyperstimulated women undergoing assisted reproduction;Alvarez;Journal of Clinical Endocrinology and Metabolism,2007

5. Cabergoline for reducing ovarian hyperstimulation syndrome in assisted reproductive technology treatment cycles. A prospective randomized controlled trial;Amir;Journal of Reproductive Medicine,2015

Cited by 33 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Calcium versus cabergoline for prevention of ovarian hyperstimulation syndrome: A systematic review and meta-analysis;European Journal of Obstetrics & Gynecology and Reproductive Biology;2024-10

2. Diagnosis and management of infertility: NICE-adapted guidelines from the Italian Society of Human Reproduction;Reproductive Biology and Endocrinology;2024-01-05

3. The HERA (Hyper-response Risk Assessment) Delphi consensus for the management of hyper-responders in in vitro fertilization;Journal of Assisted Reproduction and Genetics;2023-09-15

4. Antiangiogenic Effect of Dopamine and Dopaminergic Agonists as an Adjuvant Therapeutic Option in the Treatment of Cancer, Endometriosis, and Osteoarthritis;International Journal of Molecular Sciences;2023-06-15

5. Does cabergoline administration affect endometrial VEGFR-2 expression in a rat model of ovarian hyperstimulation syndrome?;Gynecological Endocrinology;2023-05-29